Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-thalassemia | Haematologica
![PDF] Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: Lesson from Günther disease model](https://i1.rgstatic.net/publication/309957914_Hemolytic_anemia_repressed_hepcidin_level_without_hepatocyte_iron_overload_Lesson_from_Gunther_disease_model/links/5e1ee05692851c3cbe657577/largepreview.png "PDF] Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: Lesson from Günther disease model")
PDF] Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: Lesson from Günther disease model
Haematologica, Volume 107, Issue 11 by Haematologica - Issuu
Vol. 102 No. 4 (2017): April, 2017 | Haematologica
Hydroxyurea differentially modulates activator and repressors of γ-globin gene in erythroblasts of responsive and non-responsiv
Haematologica, Volume 102, issue 12 by Haematologica - Issuu
Cancers | Free Full-Text | Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia?
Untitled
Haematologica, Volume 105, Issue 10 by Haematologica - Issuu
Haematologica, Volume 104, Issue 5 by Haematologica - Issuu
Haematologica, Volume 104, Issue 4 by Haematologica - Issuu
Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective | Haematologica
Hydroxyurea differentially modulates activator and repressors of γ-globin gene in erythroblasts of responsive and non-responsive patients with sickle cell disease in correlation with Index of Hydroxyurea Responsiveness | Haematologica
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica
Haematologica, Volume 106, Issue 9 by Haematologica - Issuu
Vol. 102 No. 8 (2017): August, 2017 | Haematologica
Untitled
Haematologica, Volume 106, Issue 5 by Haematologica - Issuu
Haematologica, Volume 106, Issue 2 by Haematologica - Issuu
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease | Haematologica
Untitled
